Chronic pain is a common disorder for which healthcare providers often prescribe controlled substances, such as opioids. Prescription opioids can alleviate pain in certain patients, but the risk of misuse, abuse, addiction, and overdose means providers need to evaluate the risks and benefits for each patient. This course will educate healthcare providers on the role of prescription controlled substances along with other therapies for chronic pain, using recommendations from current national guidelines. Upon completion of this course, providers should be able to identify which patients can benefit from chronic opioid therapy while monitoring for necessary adjustments during the course of their treatment.
The goal of this course is to educate healthcare providers on methods for safe and responsible administration of controlled substances for the management of chronic pain.
Chronic pain is a common disorder for which healthcare providers often prescribe controlled substances, such as opioids. Prescription opioids can alleviate pain in certain patients, but the risk of misuse, abuse, addiction, and overdose means providers need to evaluate the risks and benefits for each patient. This course will educate healthcare providers on the role of prescription controlled substances along with other therapies for chronic pain, using recommendations from current national guidelines. Upon completion of this course, providers should be able to identify which patients can benefit from chronic opioid therapy while monitoring for necessary adjustments during the course of their treatment. The goal of this course is to educate healthcare providers on methods for safe and responsible administration of controlled substances for the management of chronic pain.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Florida Board of Pharmacy (CEBroker Provider #50-290)
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
District of Columbia Board of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Florida Board of Nursing (CEBroker Provider #50-290)
Georgia Board of Nursing (CEBroker Provider #50-290)
South Carolina Board of Nursing (CEBroker Provider #50-290)
West Virginia Board of Registered Nursing (CEBroker Provider #50-290)
New Mexico Board of Nursing (CEBroker Provider #50-290)
Arkansas State Board Of Nursing Approved Continuing Education program (CEBroker Provider #50-290).
Kentucky Board of Nursing (CEBroker Provider #50-290)
Nurses will receive 1.25 contact hours for participating in this course.
Mississippi Board of Nursing (CEBroker Provider #50-290)
North Dakota Board of Nursing (CEBroker Provider #50-290)
Florida Board of Medicine (CEBroker Provider #50-290)
Physicians will receive 1.25 AMA PRA category 1 Credits™.
State Medical Board of Ohio (CEBroker Provider #: 50-290)
Louisiana State Board of Medical Examiners (CEBroker Provider #: 50-290)
Mississippi State Board of Medical Licensure (CEBroker Provider #: 50-290)
Physicians will receive 1.25 AMA PRA category 1 Credits™.
South Carolina Board of Medical Examiners (CEBroker Provider #50-290)
Tennessee Board of Medical Examiners (CEBroker Provider #50-290)>
Physicians will receive 1.25 AMA PRA category 1 Credits™
Florida Physician Assistants (CEBroker Provider #50-290)
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Chronic Pain
Background
Definition
Pathogenesis of Chronic Pain
Section 3: Managing Patients With Chronic Pain
Evaluation of Patient With Chronic Pain
Determining Treatment for Chronic Pain
Nonpharmacologic Treatments for Chronic Pain
Nonopioid Treatment for Chronic Pain
Section 4: Using Controlled Substances for Chronic Pain
Controlled Substances for Chronic Pain
Initiating Opioids
Adjusting and Converting Opioid Therapy
Opioid Prescribing in the Older Adult
Monitoring Patients with Chronic Pain
Summary
Section 5: Clinical Vignette
Meet Ms. Fitch
Section 6: Conclusion
Course Summary
Course Contributors
Resources
References
Doug earned his Doctor of Pharmacy (PharmD) from the Raabe College of Pharmacy at Ohio Northern University in 2011. He completed a PGY-1 residency in Pharmacy Practice at MetroHealth Medical Center in Cleveland, Ohio, and completed a specialty residency in Drug Information and Medical Information at Duke University Hospital and GlaxoSmithKline. He is a board-certified pharmacotherapy specialist, and has worked as a clinical pharmacist within the Center for Medication Policy of the Duke University Health System since 2013. His primary responsibilities include chairing the Pharmaceutical Utilization Management Program and Medication Alert Optimization Committee for the health system. He also serves as an APPE preceptor, PGY-1 residency coordinator, and is a member of the Duke University Health System Institutional Review Board.Writer: Sooa Devereaux, MSN, RN
Sooa Devereaux, MSN, RN, has a long history of professional development experience within the hospital setting. She has taught in pre-licensure nursing programs and has mentored many nurses, both new graduate and experienced, throughout her career as a nurse educator. Sooa is a Lead SME Writer at Relias and holds an MSN in Nursing Education.
Access to over 1,450 courses! Access to 1,450+ courses for one low price.